ETHYL (S)-2-(BENZYLOXY)PROPIONATE
|
- $215 - $845
- Product name: ETHYL (S)-2-(BENZYLOXY)PROPIONATE
- CAS: 54783-72-1
- MF: C12H16O3
- MW: 208.25
- EINECS:
- MDL Number:MFCD00136861
- Synonyms:ETHYL (S)-2-(BENZYLOXY)PROPIONATE;(-)-(S)-Ethyl 2-(benzyloxy)propanoate;(2S)-2-(PhenylMethoxy)propanoic Acid Ethyl Ester;(S)-2-Benzyloxypropionic Acid Ethyl Ester;Levofloxacin Methyl (R)-2-(Benzyloxy)propionate;Propanoic acid, 2-(phenylmethoxy)-, ethyl ester, (2S)-;Ethyl (S)-2-(Benzyloxy)propanoate
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Medical Isotopes, Inc.
- TRC
Package
- 1G
- 2g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCCH0006064
- Product descriptionETHYL-(S)-2-(BENZYLOXY)PROPIONATE 95.00%
- Packaging1G
- Price$704.55
- Updated2021-12-16
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product number10004
- Product descriptionEthyl(S)-2-(Benzyloxy)propionate
- Packaging1g
- Price$845
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberE900010
- Product descriptionEthyl(S)-2-(Benzyloxy)propionate
- Packaging2g
- Price$215
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CCH0006064 | ETHYL-(S)-2-(BENZYLOXY)PROPIONATE 95.00% | 1G | $704.55 | 2021-12-16 | Buy |
| Medical Isotopes, Inc. | 10004 | Ethyl(S)-2-(Benzyloxy)propionate | 1g | $845 | 2021-12-16 | Buy |
| TRC | E900010 | Ethyl(S)-2-(Benzyloxy)propionate | 2g | $215 | 2021-12-16 | Buy |
Properties
Boiling point :90-96°C/0.5mm
storage temp. :-20°C Freezer
solubility :Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
form :Oil
color :Clear Colourless
storage temp. :-20°C Freezer
solubility :Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
form :Oil
color :Clear Colourless
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|